News

Disc Medicine, Inc, a biopharmaceutical company focusing on innovative treatments for severe hematologic diseases, has announced that the United States Food and Drug Administration

AffaMed Therapeutics, a prominent biotechnology company specializing in developing and commercializing innovative pharmaceutical and surgical products for unmet needs in ophthalmology

Certa Therapeutics, a biotechnology company specializing in precision therapies for inflammatory and fibrotic diseases, has announced that the U.S. Food and Drug Administration has granted Fast Track Designation for its investigational therapy

Iovance Biotherapeutics, Inc, a biotechnology company focused on developing novel polyclonal tumor infiltrating lymphocyte cell therapies for cancer patients, has received approval from the U.S. Food and Drug Administration

Intellia Therapeutics, Inc. and ReCode Therapeutics have announced a collaborative effort to develop innovative genomic medicines for cystic fibrosis, a genetic disease that affects various organs,

Bristol Myers Squibb has shared that the U.S. Food and Drug Administration accepted the supplemental New Drug Application for Augtyro™ aimed at treating solid tumors in adults and pediatric patients aged 12 and above

Atara Biotherapeutics, Inc, a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases,

DelSiTech Ltd., a company specializing in clinical-stage drug delivery and development, has announced a global license and development agreement with Tolmar International Ltd., a fully-integrated pharmaceutical company.

Krystal Biotech, Inc, a biotechnology company, announced today that the U.S. Food and Drug Administration has granted Fast Track Designation for inhaled KB707. This designation aims to expedite the development

HTuO Biosciences, a biotech company specializing in molecular simulation for drug discovery, has recently joined Johnson & Johnson Innovation - JLABS as a resident virtual company.